Takeda Pharmaceutical Company Limited TAK
$ 13.94
0.54%
Quarterly report 2022-Q1
added 06-29-2022
Country |
- |
IPO year |
2018 |
Industry |
Drug manufacturers |
Stock Exchange |
NYSE |
CEO |
Mr. Christophe Weber |
Employees in the company |
47 495 |
Shares |
1.56 B |
Market Cap[1] |
$ 21.8 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.